Standout Papers

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after complet... 2003 2026 2010 2018 1.7k
  1. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer (2005)
    Anthony Howell, Jack Cuzick et al. The Lancet
  2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial (2010)
    Jack Cuzick, Ivana Šestak et al. The Lancet Oncology
  3. Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 (2007)
    Alan S. Coates, Aparna Keshaviah et al. Journal of Clinical Oncology
  4. Overview of the main outcomes in breast-cancer prevention trials (2003)
    Jack Cuzick, T.J. Powles et al. The Lancet
  5. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen (2009)
    Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology
  6. Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study (2010)
    Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology
  7. Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer (2011)
    Jack Cuzick, Mitch Dowsett et al. Journal of Clinical Oncology
  8. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy (2010)
    Andrew W. Bradbury, Donald J. Adam et al. Journal of Vascular Surgery
  9. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V (2016)
    Marco Colleoni, Zhuoxin Sun et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 11 from Science/Nature 106 standout
Sub-graph 1 of 17

Citing Papers

The neuroscience of cancer
2023 StandoutNature
Breast cancer
2021 Standout
66 intermediate papers

Works of John Forbes being referenced

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
2019
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
2015
and 34 more

Author Peers

Author Last Decade Papers Cites
John Forbes 6627 8022 5839 201 16.1k
Victor G. Vogel 5350 7829 6557 167 15.7k
Michael Baum 5660 6168 3420 276 13.0k
James N. Atkins 4288 8174 3782 107 14.1k
Beat Thürlimann 9893 10662 5388 212 17.5k
R. Jakesz 5099 6980 2991 331 11.8k
Judith M. Bliss 4847 6711 1858 270 13.4k
Henning T. Mouridsen 6558 7858 2495 242 13.8k
Paul D.P. Pharoah 4706 6484 5883 336 19.2k
Alan S. Coates 11056 14199 4826 297 23.4k
Vera J. Suman 3511 6892 2192 270 14.4k

All Works

Loading papers...

Rankless by CCL
2026